India · Delayed Price · Currency is INR Aurobindo Pharma Company Description
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables.
The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology.
It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams.
The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
| Country | India |
| Founded | 1986 |
| Industry | Pharmaceutical Preparations |
| Employees | 27,707 |
| CEO | Kambam Reddy |
Contact Details
Address: Galaxy, Plot No. 1 Hyderabad, 500032 India | |
| Phone | 91 40 6672 5000 |
| Website | aurobindo.com |
Stock Details
| Ticker Symbol | 524804 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Kambam Reddy | Chief Executive Officer |
| Santhanam Subramanian | Chief Financial Officer |
| K.P Shetty | Chief Operating Officer |